Chargement en cours...
Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
We report asialoglycoprotein receptor (ASGPR)-targeted doxorubicin hydrochloride (Dox) nanoparticles (NPs) for hepatocellular carcinoma (HCC). Polyethylene sebacate (PES)-Gantrez® AN 119 Dox NPs of average size 220 nm with PDI < 0.62 and ∼20% Dox loading were prepared by modified nanoprecipitatio...
Enregistré dans:
| Publié dans: | Drug Deliv |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8244555/ https://ncbi.nlm.nih.gov/pubmed/28155331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2016.1225856 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|